Skip to main content

DIADEMA PARTNERS LP

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
181,752
-47.5% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
64,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 181,752
2025-12-31 64,700
2025-12-31 345,880
2025-09-30 323,159
2025-09-30 225,200
2025-06-30 160,900
2025-06-30 259,852
2025-03-31 56,098
2024-12-31 50,370